Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: The CREDENTIAL study

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 3, 2013, Pages

  Mischie, Alexandru Nicolae ^a,b   Nazzaro, Marco Stefano ^a   Fiorilli, Rosario ^a   De Felice, Francesco ^a   Musto, Carmine ^a   Confessore, Pierpaolo ^a   Parma, Antonio ^a   Boschetti, Carla ^a   Violini, Roberto ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b Bagdasar Arseni Emergency Hospital   (Romania)

Author keywords

acetylcholine; endothelial function; endothelium

Indexed keywords

RAPAMYCIN;

AGED; ARTICLE; BARE METAL STENT; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ENDOTHELIAL DYSFUNCTION; DRUG ELUTING STENT; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VASOCONSTRICTION;

ACETYLCHOLINE; ENDOTHELIAL FUNCTION; ENDOTHELIUM;

ACETYLCHOLINE; AGED; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METALS; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; ROME; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84883239725     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24844     Document Type: Article

References (19)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R,. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ,. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-1193.
3. Drexler H, Zeiher AM,. Progression of coronary endothelial dysfunction in man and its potential clinical significance. Basic Res Cardiol 1991; 86 (Suppl 2): 223-232.
4. Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, Kim K, Shindo T, Kimura K,. Progression of coronary atherosclerosis: Is coronary spasm related to progression? J Am Coll Cardiol 1991; 18: 904-910.
5. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A,. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
6. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA,. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 653-658.
7. Heitzer T, Schlinizing T, Krohn K, Meinertz T, Munzel T,. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
8. Kim JW, Seo HS, Park JH, et al. A Prospective, Randomized, 6 months comparison of the coronary vasomotor response associated with a zotarolimus versus a sirolimus eluting stent: Diferential recovery of coronary endothelial dysfunction. J Am Coll Cardiol 2009; 53; 1653-1659.
9. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM,. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46: 231-6.
10. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW,. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 166-170.
11. Fuke S, Maekawa K, Kawamoto K, Saito H, Sato T, Hioka T, Ohe T,. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 2007; 71: 220-225.
12. Caramori PRA, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG,. Long-term endothelial dysfunction after coronary artery stenting. J Am Coll Cardiol 1999; 34: 1675-1679.
13. Farouque HMO, Meredith IT,. The assessment of endothelial function in humans. Coron Artery Dis 2001; 12: 445-454.
14. Maseri A, Davies G, Hackett D, Kaski JC,. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990; 81: 1983-1991.
15. Schachinger V, Britten MB, Zeiher AM,. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
16. Bonetti PO, Lerman LO, Lerman A,. Endhotelial dysfunction: A marker of atherosclerotic risk. Aterioscler Thromb Vasc Biol 2003; 23: 168-175.
17. Brott BC, Anayiotos AS, Chapman GD, Anderson PG, Hillegass WB,. Severe, diffuse coronary artery spasm after drug eluting-stent placement. Invasive Cardiol 2006; 18: 584-592.
18. Maekawa K, Kawamoto K, Fuke S, Yoshioka R, Saito H, Sato T, Hoioka T,. Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus eluting stent implantation. Circulation 2006; 113: e850-e851.
19. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NAF, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL,. Drug-eluting stent in preclinical studies. Updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv 2008; 1: 143-153.